Ocugen OCGN
NASDAQ OCGN
$1.00 -0.03 (-2.91%)
As of: Oct 1, 2026 · 3:59 PM EDT

Ocugen (OCGN) Depreciation & Amortization (CF) (2014 - 2026)

Updated

Ocugen (OCGN) posted Depreciation & Amortization (CF) of $586,000 for Q2 2026, down 52.8% from $1.24 million a year earlier and down 0.7% from the prior quarter.

Analysis

Ocugen (OCGN) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Ocugen was $1.73 million, down 43.3% year-over-year; for FY2025, it was $2.39 million, up 21.4% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for seven consecutive years, with a five-year compound annual growth rate of 87.9% (FY2020 to FY2025).
  • In prior years, Ocugen's Depreciation & Amortization (CF) was $1.97 million in FY2024 (+179.5%), $704,000 in FY2023 (+46.7%), $480,000 in FY2022 (+109.6%) and $229,000 in FY2021 (+124.5%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of -$397,000 in Q4 2025 to a high of $1.24 million in Q2 2025 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) increased in five of the last seven quarters, with growth averaging 118.4%.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q3 2024, with growth of 246.3%; the weakest was Q2 2026, with a decline of 52.8%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $590,000 (Q1 2026), -$397,000 (Q4 2025) and $950,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Ocugen 349.22 Mn 165.73 Mn - 586,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 586,000.00
Mar 31, 2026 590,000.00
Dec 31, 2025 -397,000.00
Sep 30, 2025 950,000.00
Jun 30, 2025 1.24 Mn
Mar 31, 2025 595,000.00
Dec 31, 2024 598,000.00
Sep 30, 2024 613,000.00
Jun 30, 2024 578,000.00
Mar 31, 2024 179,000.00
Dec 31, 2023 179,000.00
Sep 30, 2023 177,000.00
Jun 30, 2023 174,000.00
Mar 31, 2023 174,000.00
Dec 31, 2022 173,000.00
Sep 30, 2022 141,000.00
Jun 30, 2022 90,000.00
Mar 31, 2022 76,000.00
Dec 31, 2021 78,000.00
Sep 30, 2021 58,000.00
API Access

Ocugen Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=OCGN&period=max&api_key=YOUR_API_KEY